US Critical Metals Corp
USCM
Mydecine Innovations Group Inc
MYCO
Three Valley Copper Corp
TVC.H
Tuga Innovations Inc
TUGA
Windfall Geotek Inc
WIN
(Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||||||
Cash flow from continuing operating activities | 75.10%-61.87K | 84.72%-53.33K | -242.92%-1.49M | 46.94%-79.33K | -816.76K | -248.48K | -349.13K | -435.58K | -149.51K |
Net income from continuing operations | -380.47%-714.59K | 66.92%-88.26K | 81.42%-729.22K | 96.55%-40.3K | ---676.92K | --254.78K | ---266.78K | ---3.92M | ---1.17M |
Operating gains losses | ---- | ---- | -88.39%58.39K | -100.39%-1.89K | ---2.03K | --31.47K | --30.84K | --503.07K | --483.69K |
Unrealized gains and losses of investment securities | 96.84%-17.31K | 133.75%29.65K | -126.64%-786.48K | -97.63%11.23K | ---162.72K | ---547.15K | ---87.84K | --2.95M | --474.54K |
Remuneration paid in stock | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --19.05K | --1.7K |
Change In working capital | -140.02%-4.97K | 120.86%5.29K | -359.85%-36.39K | -183.35%-48.37K | --24.91K | --12.42K | ---25.35K | --14.01K | --58.03K |
-Change in receivables | 62.87%-3.59K | 254.55%12.96K | -3,916.94%-19.44K | -235.15%-16.86K | --15.45K | ---9.65K | ---8.38K | ---484 | --12.47K |
-Change in prepaid assets | ---- | ---- | ---- | ---- | ---1.59K | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | -99.99%2 | 54.78%-7.67K | -216.99%-16.95K | -172.66%-33.1K | --11.05K | --22.07K | ---16.96K | --14.49K | --45.56K |
Cash from discontinued investing activities | |||||||||
Operating cash flow | 75.10%-61.87K | 84.72%-53.33K | -242.92%-1.49M | 46.94%-79.33K | ---816.76K | ---248.48K | ---349.13K | ---435.58K | ---149.51K |
Investing cash flow | |||||||||
Cash flow from continuing investing activities | 0 | 0 | 121.46%99.34K | 130.69%166.23K | 467.54K | -284.66K | -249.78K | -462.86K | -541.57K |
Net investment purchase and sale | --0 | --0 | 121.46%99.34K | 130.69%166.23K | --18.7K | --0 | ---85.6K | ---462.86K | ---541.57K |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---284.66K | ---164.18K | ---- | ---- |
Cash from discontinued investing activities | |||||||||
Investing cash flow | --0 | --0 | 121.46%99.34K | 130.69%166.23K | --467.54K | ---284.66K | ---249.78K | ---462.86K | ---541.57K |
Financing cash flow | |||||||||
Cash flow from continuing financing activities | 0 | 0 | -80.86K | 0 | |||||
Net issuance payments of debt | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---48.11K | --0 |
Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---52.75K | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20K | --0 |
Cash from discontinued financing activities | |||||||||
Financing cash flow | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---80.86K | --0 |
Net cash flow | |||||||||
Beginning cash position | -81.11%197.65K | -84.75%250.99K | -37.31%1.65M | -92.98%164.08K | --513.31K | --1.05M | --1.65M | --2.62M | --2.34M |
Current changes in cash | 88.39%-61.87K | 91.10%-53.33K | -42.38%-1.39M | 112.57%86.9K | ---349.22K | ---533.14K | ---598.91K | ---979.3K | ---691.08K |
End cash Position | -73.55%135.78K | -81.11%197.65K | -84.75%250.99K | -84.75%250.99K | --164.08K | --513.31K | --1.05M | --1.65M | --1.65M |
Free cash from | 75.10%-61.87K | 84.72%-53.33K | -242.92%-1.49M | 46.94%-79.33K | ---816.76K | ---248.48K | ---349.13K | ---435.58K | ---149.51K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.